课题基金 / 基金详情

项目摘要

项目成果

Jordi Ochando的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/摘要 Tisch癌症研究所(TCI)流式细胞术共享资源设施(FCSRF)为TCI成员提供 获得最先进的技术和专业知识,以成功开展科学研究 项目流式细胞术是一种强大的技术,使研究人员能够同时研究 每秒数千个细胞的多参数特性,以破译复杂的细胞和分子 健康和疾病的过程。FCSRF包括机构流式细胞仪核心和两个TCI 卫星站点。FCSRF配备了生物安全等级2+的六台分析仪和六台细胞分选仪 专门用于分离感染II类病原体的非固定人体样本和小鼠细胞的区域。在 此外,两个卫星站配备了四台分析仪。配备7名流式细胞仪专家 战略储备基金100%地致力于该设施,它提供的业务、培训和咨询服务涵盖所有 流式细胞术的各个方面,包括基本的细胞生物学原理、分析、分离单细胞, 癌症患者,并在同一细胞上鉴定超过30种不同的细胞表面/细胞内抗原 使用革命性的Aurora平台。FCSRF还为基础应用提供服务,例如 单细胞分离,以支持创新和复杂的生物学研究,涉及RNA测序,ChIP测序,ATAC, seq和CITE-seq以及蛋白质组学、代谢组学和脂质组学分析。考虑到这一点,我们 使命是提供必要的仪器和专业知识,有关流式细胞仪分析和细胞 分类,以便TCI实验室通过基本的方法提高人类癌症知识,诊断和治疗 科学、转化和临床研究。
英文摘要
PROJECT SUMMARY/ABSTRACT The Tisch Cancer Institute (TCI) Flow Cytometry Shared Resource Facility (FCSRF) provides TCI members with access to state-of-the-art technology and expertise for the successful development of scientific research projects. Flow cytometry is a powerful technology that enables researchers to study simultaneous multiparametric characteristics of thousands of cells per second to decipher complex cellular and molecular processes in health and disease. The FCSRF comprises the institutional Flow Cytometry Core and two TCI satellite sites. The FCSRF is equipped with six analyzers and six cell sorters contained in biosafety level 2+ areas dedicated to isolate non-fixed human samples and mouse cells infected with class II pathogens. In addition, two satellite sites are equipped with four analyzers. Staffed with seven flow cytometry specialists committed at 100% to this facility, the SRF provides operational, training, and consultation services covering all aspects of flow cytometry including fundamental cell biology principles, analyses, isolation single cells from cancer patients, and identification of over thirty different cell surface/intracellular antigens on the same cell using the revolutionary Aurora platform. The FCSRF also offers services for fundamental applications, such as single cell isolation, to support innovative and complex biological studies involving RNA-seq, ChIP-seq, ATAC- seq, and CITE-seq together with proteomics, metabolomics, and lipidomics profiling. With this in mind, our mission is to provide the necessary instrumentation and expertise regarding flow cytometry analyses and cell sorting so that TCI laboratories improve human cancer knowledge, diagnosis, and treatment through basic sciences, translational, and clinical research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanistic and Bioinformatics Core
Myeloid Specific Targeted Nanoimunotherapy for Organ Transplant Acceptance
Myeloid Specific Targeted Nanoimunotherapy for Organ Transplant Acceptance
Flow Cytometry
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究